QurAlis Grants Lilly Exclusive Global License for QRL-204, a Potentially First-in-Class Precision Therapy That Restores UNC13A Function in ALS and FTD



Comments are closed.

Digilens Series D led by Samsung Electronics
Cerevance Expands Series B Financing to $65 Million
EarGo Raises Over $140m in Upsized Initial Public Offering
GE Lighting and ShotSpotter Sign MOU to Bring Gunshot Detection to Luminaires